Boston Sci Slammed After Cyberattack Hamstrings Sales

Live updates

1. 5d ago

   Boston Scientific Misses 2026 Forecasts Following Cyberattack

   Boston Scientific will likely miss its 2026 sales and profit guidance after a cyberattack disrupted operations. The company indicated it is unlikely to meet its earnings forecasts, leading to a drop in stock price. The attack hampered sales capabilities, forcing the medical device firm to revise its financial expectations for the year. Multiple financial news outlets confirm the company's inability to reach previously stated targets due to the security breach.

   Why it matters

   Financial guidance serves as a benchmark for investor expectations and company health. A failure to meet these forecasts often triggers immediate market volatility. This incident highlights the vulnerability of medical technology supply chains to digital disruption.

   What is confirmed

   • Boston Scientific is unlikely to meet its 2026 sales and profit forecasts.
   • A cyberattack caused the company to miss its earnings guidance.
   • The company's stock price fell following the announcement.

   What to watch next

   • Disclosure of the specific nature or origin of the cyberattack
   • Revised 2026 financial guidance figures
   • Details on the extent of sales disruptions
   Sources used for this update (5)

   1. wsj.com — Boston Scientific Won’t Meet Guidance Due to Cyberattack
   2. Reuters — Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
   3. Bloomberg.com — Boston Scientific Unlikely to Meet Forecasts After Cyber Attack
   4. Barron's — Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.
   5. Investor's Business Daily — Boston Sci Slammed After Cyberattack Hamstrings Sales
   confidence 100%